ASSOCIATION OF VITAMIN D DEFICIENCY WITH METABOLIC DISORDERS IN PATIENTS WITH OBESITY

Authors

  • G’aniyeva Charos Shuxrat qizi Tashkent Region Ahangaran City Medical Association and Ahangaran City Medical Center Author

Keywords:

vitamin D deficiency, obesity, metabolic disorders, insulin resistance, glucose metabolism, dyslipidemia, hypertension, inflammation, 25-hydroxyvitamin D, metabolic syndrome.

Abstract

Vitamin D deficiency is frequently observed in individuals with obesity and has attracted increasing attention because of its potential association with metabolic disturbances. This article examines the relationship between vitamin D deficiency and metabolic disorders in patients with obesity, with particular emphasis on insulin resistance, impaired glucose metabolism, dyslipidemia, hypertension, and chronic low-grade inflammation. The possible mechanisms underlying this association include sequestration of vitamin D in adipose tissue, reduced bioavailability, limited outdoor activity, altered vitamin D metabolism, and interactions between vitamin D signaling and metabolic pathways. Current evidence suggests that low serum 25-hydroxyvitamin D concentrations are common among people with obesity and may be associated with an unfavorable metabolic profile. However, the direction and clinical significance of this relationship remain incompletely established because obesity, lifestyle, diet, physical activity, and other factors may act as confounders.

References

1.Holick, M.F. Vitamin D deficiency. New England Journal of Medicine, 2007, 357(3), 266–281.

2.Holick, M.F. Vitamin D: Photobiology, metabolism, mechanism of action, and clinical applications. In: Endocrinology. Williams Textbook of Endocrinology.

3.Wortsman, J., Matsuoka, L.Y., Chen, T.C., Lu, Z., Holick, M.F. Decreased bioavailability of vitamin D in obesity. American Journal of Clinical Nutrition, 2000, 72(3), 690–693.

4.Pereira-Santos, M., Costa, P.R.F., Assis, A.M.O., Santos, C.A.S.T., Santos, D.B. Obesity and vitamin D deficiency: A systematic review and meta-analysis. Obesity Reviews, 2015, 16(4), 341–349.

5.Vimaleswaran, K.S., Berry, D.J., Lu, C., et al. Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Medicine, 2013, 10(2), e1001383.

6.Pittas, A.G., Lau, J., Hu, F.B., Dawson-Hughes, B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. Journal of Clinical Endocrinology & Metabolism, 2007, 92(6), 2017–2029.

7.Muscogiuri, G., Sorice, G.P., Prioletta, A., et al. 25-Hydroxyvitamin D concentration correlates with insulin-sensitivity and BMI in obesity. Obesity, 2010, 18(10), 1906–1910.

8.Mathieu, C., Gysemans, C., Giulietti, A., Bouillon, R. Vitamin D and diabetes. Diabetologia, 2005, 48, 1247–1257.

9.Bouillon, R., Marcocci, C., Carmeliet, G., et al. Skeletal and extraskeletal actions of vitamin D: current evidence and outstanding questions. Endocrine Reviews, 2019, 40(4), 1109–1151.

10.Pilz, S., Kienreich, K., Rutters, F., et al. Role of vitamin D in the development of cardiovascular disease and metabolic disorders. Endocrine Reviews, relevant literature.

11.Rosen, C.J., Abrams, S.A., Aloia, J.F., et al. IOM committee members respond to Endocrine Society vitamin D guideline. Journal of Clinical Endocrinology & Metabolism, 2012.

12.LeFevre, M.L. Screening for vitamin D deficiency: U.S. Preventive Services Task Force recommendation statement. Annals of Internal Medicine, 2015, 162(2), 133–140.

Downloads

Published

2026-08-30